Q1 EPS Forecast for MiNK Therapeutics Decreased by Analyst
MiNK Therapeutics, Inc. (NASDAQ:INKT – Free Report) – Equities research analysts at HC Wainwright cut their Q1 2025 earnings per share estimates for shares of MiNK Therapeutics in a report released on Tuesday, March 18th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($0.63) for the quarter, […]
MiNK Therapeutics, Inc. (NASDAQ:INKT – Free Report) – Equities research analysts at HC Wainwright cut their Q1 2025 earnings per share estimates for shares of MiNK Therapeutics in a report released on Tuesday, March 18th. HC Wainwright analyst E. Bodnar now anticipates that the company will post earnings per share of ($0.63) for the quarter, […]
